
You are here
Scheduling delegate's interim decisions and invitation for further comment: ACCS/ACMS, March 2016
Print version
Scheduling medicines and poisons
12 May 2016
3 Summary
Part A - Interim decisions on scheduling proposals referred to an advisory committee (March 2016)
3. Advisory Committee on Medicines Scheduling (ACMS#17)
Substance | Interim decision |
---|---|
Cannabis | The Delegate's interim decision on Cannabis and Tetrahydrocannabinol has been published separately. |
Codeine | The Delegate's decision relating to scheduling of codeine will be made after June 2016. |
Benzodiazepines |
Schedule 9 - New entriesDICYCLAZEPAM PYRAZOLAM CLONAZOLAM DESCHLOROETIZOLAM FLUBROMAZEPAM NIFOXIPAM MECLONAZEPAM Proposed implementation date: 1 October 2016. |
Ketoprofen | The current scheduling remains appropriate |
Naproxen | The current scheduling remains appropriate |
Paracetamol |
Schedule 2 – Amend entryPARACETAMOL for therapeutic use:
Schedule 4 – Amend entryPARACETAMOL:
Proposed implementation date: 1 October 2016. |
Loratadine |
Schedule 2 – Amend entryLORATADINE in preparations for oral use except in divided preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:
Schedule 4 – Amend entryLORATADINE except:
Proposed implementation date: 1 October 2016. |